IXC
Invex Therapeutics Ltd
1 day chart
About IXC
Invex Therapeutics Ltd (ASX: IXC) is a clinical-stage biopharmaceutical company focused on the development and commercialisation of Presendin (sustained release Exenatide) for neurological conditions relating to raised intracranial pressure.
Buy Australian shares starting with IXC. Invest today with a CHESS-sponsored investing platform!
Market Capitalisation
$15M
Price-earnings ratio
-1.99
Dividend yield
NaN%
High today
$0.21
Low today
$0.20
Open price
$0.20
52-week high
$0.66
52-week low
$0.15
Announcements
IXC FAQs
Can I buy IXC shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake platform allows you to buy IXC shares and over 8,000 stocks and ETFs across the ASX and Wall St.
How much is one share of Invex Therapeutics Ltd?
One share of Invex Therapeutics Ltd is valued at $0.21.
What is the ticker symbol for Invex Therapeutics Ltd?
The ticker symbol for Invex Therapeutics Ltd is IXC.
How do I buy IXC shares in Australia?
To buy IXC stocks in Australia you'll need to open an account with an investing platform like Stake.
To do so follow these steps:
To do so follow these steps:
- Sign up in minutes, all you need is some I.D.
- Choose Stake AUS
- Deposit directly into your Stake wallet and you're ready to invest in IXC
What is the 52-week high for Invex Therapeutics Ltd stock?
The Invex Therapeutics Ltd 52-week high stock price is $0.66.
What is the 52-week low for Invex Therapeutics Ltd stock?
The Invex Therapeutics Ltd 52-week low stock price is $0.15.
What is the market capitalisation of Invex Therapeutics Ltd IXC?
As of 02/10/2023 Invex Therapeutics Ltd has a market cap of $15M.
Related Stocks
This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.